InMed Pharmaceuticals INM
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 1.06 | 10 | -19.15 | -2 | -16.52 | 11 |
| 2025Q3 | 2.19 | 12 | -13.80 | -2 | -11.93 | 13 |
| 2025Q2 | 3.25 | 13 | -17.48 | -2 | -14.38 | 16 |
| 2025Q1 | 2.07 | 7 | -32.13 | -2 | -23.86 | 9 |
| 2024Q4 | 4.74 | 6 | -35.33 | -3 | -27.15 | 9 |
| 2024Q3 | 4.74 | 8 | -19.07 | -2 | -15.06 | 10 |
| 2024Q2 | 5.31 | 9 | -19.08 | -2 | -15.39 | 12 |
| 2024Q1 | 7.28 | 11 | -14.43 | -2 | -12.04 | 13 |
| 2023Q4 | 8.32 | 13 | -13.23 | -1 | -11.29 | 15 |
| 2023Q3 | 14.00 | 10 | -23.42 | -3 | -20.28 | 11 |
| 2023Q2 | 18.53 | 12 | -2.76 | 0 | -2.34 | 14 |
| 2023Q1 | 21.60 | 12 | -14.95 | -2 | -12.63 | 15 |
| 2022Q4 | 40.40 | 14 | -16.58 | -2 | -13.34 | 17 |
| 2022Q3 | 131.87 | 11 | -34.95 | -4 | -25.65 | 15 |
| 2022Q2 | 235.20 | 9 | -78.83 | -8 | -55.67 | 13 |
| 2022Q1 | 471.35 | 11 | -27.75 | -3 | -19.94 | 15 |
| 2021Q4 | 655.00 | 14 | -29.15 | -4 | -23.33 | 19 |
| 2021Q3 | 875.00 | 15 | -26.30 | -3 | -21.93 | 17 |
| 2021Q2 | 1590.00 | 7 | -36.64 | -3 | -29.46 | 10 |
| 2021Q1 | 1650.00 | 10 | -34.45 | -3 | -25.74 | 12 |